Dr SooHo Yeo, College of Pharmacy & Yonsei Institute of Pharmaceutical Sciences, Yonsei University, South Korea
Dr. SooHo Yeo is a research professor at Yonsei University, specializing in pharmaceutics, cosmeceutics, and photodynamic therapy. He holds a Ph.D. in pharmacy from Chung-Ang University, where he focused on artificial skin formulations for topical delivery of adenosine. Dr. Yeo’s research interests include nano/micro-particles, skin absorption, and pharmacokinetic/pharmacodynamic analysis, with applications in cancer treatment and cosmetic clinical tests. He has published numerous studies on nanoparticle-based cancer therapies and anti-adhesive agents. His work contributes significantly to skin irritation, absorption studies, and enhancing anticancer therapies. 🧴💡🔬📚🎓
Publication Profile
Scopus
Education
Dr. SooHo Yeo is a distinguished scholar in the field of pharmacy, having completed his M.S./Ph.D. at the College of Pharmacy, Chung-Ang University, Seoul, Korea, in 2021. His research focused on developing innovative solutions for drug delivery, with his dissertation titled “Artificial Skin Formulation for Topical Delivery of Adenosine.” 🌱💊 His work combines pharmaceutical science and cutting-edge technology to enhance therapeutic efficacy through topical applications. Dr. Yeo’s contributions aim to revolutionize treatments by improving the delivery mechanisms of crucial compounds like adenosine, benefiting patients worldwide. 🧴🌏
Experience
Dr. SooHo Yeo is a dedicated researcher with extensive experience in the field of pharmacy and nanoscience. Since 2023, he has been a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea. Prior to this, he served as a Research Professor at the Department of Nanoscience and Engineering, INJE University, Gimhae, Korea, from 2021 to 2023. With a strong focus on advancing research in these fields, Dr. Yeo has made significant contributions to the scientific community. 🔬📚💉🌱
Research Fields
Dr. SooHo Yeo specializes in pharmaceutics and cosmeceutics, focusing on nano/micro-particles, solid dispersion, emulsions, liposomes, films, creams, and inhalers. His research integrates biology and toxicology, including in vitro skin irritation and absorption studies, using cells and reconstructed human epidermis tissues (following OECD guidelines), along with cellular uptake observed through confocal microscopy. Dr. Yeo also conducts pharmacokinetic and pharmacodynamic analysis for anti-cancer and anti-adhesive agents. His cosmetic clinical tests include skin wrinkle and moisture assessments. Additionally, he explores photodynamic therapy, advancing treatments for skin care and cancer therapies. 💉🧴🧬🔬💆♀️
Research Focus
Dr. SooHo Yeo’s research primarily focuses on nanotechnology for cancer treatment, particularly in the development of advanced drug delivery systems. His work involves the use of nanoparticles, such as PLGA and solid lipid nanoparticles, to enhance the efficacy of photodynamic therapy (PDT) and chemotherapy. Through innovative drug encapsulation methods, including for agents like Purpurin-18-N-hydroxylimide methyl ester, Dr. Yeo aims to improve therapeutic outcomes in cancer treatment. His studies also explore the use of smart nanoparticles for targeting specific organelles like mitochondria or lysosomes to optimize treatment precision and minimize side effects. 🧬💉🔬💊
Publication Top Notes
Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester
4-Hexylresorcinol Loaded Solid Lipid Nanoparticles for Enhancing Anticancer Activity
Enhanced Photodynamic Therapy Efficacy through Solid Lipid Nanoparticle of Purpurin-18-N-Propylimide Methyl Ester for Cancer Treatment
Polysaccharide-based emulsion gels for the prevention of postoperative adhesions and as a drug delivery system using 5-fluorouracil
Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy
Long-wavelength absorbing and mitochondria or lysosome organelle-targeting photosensitizers with flexible or rigid terminus for fluorescence imaging and high-performance photodynamic therapy
Improved anticancer efficacy of methyl pyropheophorbide-a–incorporated solid lipid nanoparticles in photodynamic therapy
Transition metal-dependent heavy-atom effect of metallochlorin photosensitizers for enhanced photodynamic therapy
pH-Responsive Nano-transferosomes of Purpurin-18 Sodium Salt and Doxorubicin for Enhanced Anticancer Efficiency by Photodynamic and Chemo Combination Therapy
Long-Wavelength Absorbing Benzimidazolo-Chlorin for Enhanced Photodynamic Therapy